Unterschiede

Hier werden die Unterschiede zwischen zwei Versionen angezeigt.

--- salvia_miltiorrhiza_bunge [2015/08/01 09:12] – andreas
+++ salvia_miltiorrhiza_bunge [2015/12/29 11:39] (aktuell) – andreas
@@ Zeile 6: / Zeile 6: @@
 [[http://www.efloras.org/florataxon.aspx?flora_id=2&taxon_id=200020230]]
-"Salvia miltiorrhiza (alone or combined with other Chinese herb medicine) was applied to the treatment of variety of diseases such as angina pectoris, myocardial infarction[33], hypertension[34], hyperlipidemia, and acute ischemic stroke." [[https://en.wikipedia.org/wiki/Salvia_miltiorrhiza]]
+"Salvia miltiorrhiza (alone or combined with other Chinese herb medicine) was applied to the treatment of variety of diseases such as angina pectoris, myocardial infarction, hypertension, hyperlipidemia, and acute ischemic stroke." [[https://en.wikipedia.org/wiki/Salvia_miltiorrhiza]]
 "Experimental studies have shown that DanShen dilated coronary arteries, increased coronary blood flow, and scavenged free radicals in ischemic diseases, so that it reduced the cellular damage from ischemia and improved heart functions. Clinical trials also indicated that DanShen was an effective medicine for angina pectoris, MI [myocardial infarct], and stroke." \\
@@ Zeile 18: / Zeile 18: @@
 A dichloromethane extract of Salvia miltiorrhiza showed a pronounced inhibitory effect on recombinant monoamine oxidase A (MAO A) and on inducible NO synthase (iNOS) induction. Four tanshinone-type diterpenoids (tanshinone IIA, 15,16-dihydrotanshinone I, cryptotanshinone and tanshinone I) were isolated. "The IC50 of the most active compound, 15,16-dihydrotanshinone I, on human recombinant MAO A was at 23mM, and 2.4mM on lipopolysaccharide-mediated iNOS induction in Raw 267.4 cells." In the MAO A and iNOS assays, tanshinone IIA was the least active compound. \\
 [HPLC-based activity profiling of Salvia miltiorrhiza for MAO A and iNOS inhibitory activities., Dittmann, K., Gerhauser, C., Klimo, K., Hamburger, M., Planta medica, 70, 2004, 909-913] [[https://www.dkfz.de/en/tox/download/gerh/pdf-files/Planta_Medica_70_909-913_2004.pdf]]
+"Salvia miltiorrhiza (SM) BUNGE or Danshen, used in treatment of various systemic and surgical infections in the hospitals of China, was able to block the lethal toxicity of LPS in mice via suppression of TNF-α release and protection on liver injury. The ability of SM to suppress LPS-induced TNF-α release is further confirmed by in vitro experiments conducted on human peripheral blood leukocytes (PBL) and the RAW 264.7 macrophage cell line... The present study explains some known biological activities of SM, and supports the clinical application of SM in the prevention of inflammatory diseases induced by Gram-negative bacteria." \\
+[Protection of lethal toxicity of endotoxin by Salvia miltiorrhiza BUNGE is via reduction in tumor necrosis factor alpha release and liver injury., Wan, J.M.F., Sit, W.H., Lee, C.L., Fu, K.H.M., Chan, D.K.O., International immunopharmacology, 6(5), 2006, 750-758]
+"Tanshinone IIA was the main diterpene quinone in S. miltiorrhiza. At the dose corresponding to its content in ethyl acetate extract, tanshinone IIA-treatment increased mouse liver microsomal MROD activity. These results demonstrated that there were mouse CYP1A, CYP2C and CYP3A-inducing agents present in the ethyl acetate extract, but not in the aqueous extract, of S. miltiorrhiza. Tanshinone IIA played a role in the induction of CYP1A by S. miltiorrhiza. The CYP induction by the ethyl acetate extract and pharmaceutical product suggested that possible drug interactions between S. miltiorrhiza and CYP substrates should be noticed." \\
+[Induction of cytochrome P450‐dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza., Lin, Y.L., Don, M.J., Kuo, Y.H., Chen, R.M., Ueng, Y.F., Journal of pharmacy and pharmacology, 58(4), 2006, 521-527]
+"Salvia miltiorrhiza root has long been used in Asian countries for clinical treatment of various microcirculatory disturbance-related diseases. This herbal drug contains many active water-soluble compounds, including protocatechuic aldehyde (PAl), 3,4-dihydroxyphenyl lactic acid (DLA) and salvianolic acid B (SalB). These compounds, as well as water-soluble fraction of S. miltiorrhiza root extract (SMRE), have an ability to scavenge peroxides and are able to inhibit the expression of adhesion molecules in vascular endothelium and leukocytes. Moreover, lipophilic compounds of SMRE also prevent the development of vascular damage; NADPH oxidase and platelet aggregation are inhibited by tanshinone IIA and tanshinone IIB, respectively, and the mast cell degranulation is blunted by cryptotanshinone and 15,16-dihydrotanshinone I. Thus, the water-soluble and lipophilic compounds of SMRE appear to improve the I/R-induced vascular damage multifactorially and synergically." \\
+[Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion., Han, J.Y., Fan, J.Y., Horie, Y., Miura, S., Cui, D.H., Ishii, H., Kimura, I., Pharmacology & therapeutics, 117(2), 2008, 280-295]
 "Danshen (Radix Salviae Miltiorrhizae, SM) is a popular traditional Chinese herb widely used in treating cardiovascular, renal, and hepatic diseases by improving circulation and resolving stasis. [[http://pubchem.ncbi.nlm.nih.gov/compound/11629084|Salvianolic acid B]] (Sal B), also known as lithospermates B or tanshinoate B, is a major water soluble component extracted from SM, which was well recognized as an antioxidative agent and free radical scavenger, involved in the protection of various cells, including nerve cells and hepatocytes. It was reported that SM and its aqueous extract, Sal B, produced a good effect in treating patients and animals with chronic renal diseases... Sal B can prevent tubular EMT [epithelial-to-mesenchymal transition] in the fibrotic kidney... the mechanism of Sal B is closely related to the regulation of TGF-β1/Smads pathway, manifested as the inhibition of TGF-β1 expression, suppression of TβR-I expression and function, down-regulation of Smad2/3 phosphorylation, and restoration of the down-regulation of Smad7, as well as inhibition of MMP-2 activity." \\
 [Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-β1 signal transduction pathway in vivo and in vitro., Wang, Q.L., Tao, Y.Y., Yuan, J.L., Shen, L., Liu, C.H., BMC cell biology, 11(1), 2010, 31] [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874764/]]
+Danshen (Salviae miltiorrhizae radix et rhizoma) is used to treat menstrual disorders, abdominal pain, myoma, ulcers and carbuncles, restlessness, sleeping disorders, palpitation and chest pain. It should contain (PhEur 7.7): min. 0.12% tanshinone IIA and min. 3.0% salvianolic acid B, (PhPRC 2010): min. 0.20% tanshinone IIA and min. 3.0% salvianolic acid B. \\
+[[http://www.lfl.bayern.de/mam/cms07/publikationen/daten/merkblaetter/chinese_medicinal_plants__cultivated_bavaria_lfl-merkblatt.pdf]]
 Tanshinone IIA was identified as a natural Monoacylglycerol lipase (MAGL) inhibitor in a concentration dependent manner (IC50 = 48 μM). "Considering being used as long-term treatment of cardiovascular diseases in China, tanshinone IIA has the potential to be developed as a good candidate for the treatment of Alzheimer's disease and other MAGL-associated diseases." \\
 [Identification of tanshinone IIA as a natural monoacylglycerol lipase inhibitor by combined in silico and in vitro approach., Yang, R., Lu, Y., Liu, J., MedChemComm, 5(10), 2014, 1528-1532]